Kromek Share Discussion Threads

[pistonbroke1] 27/2/2017 16:59

Good Day but it appears our seller is still there in the background. Despite heavy buying in the later part of the day the offer stayed put and even decreased by a little.
We may get a reduced holdings RNS in the next day or so, however, with this volume it's a good opportunity to clear them out.

[pistonbroke1] 27/2/2017 16:09

426K trade just gone through.

[trotterstrading] 27/2/2017 14:35

There is no reason for pull back nOw cash balance sheet has a nice credit of £20m and AMP the 'seller' has gone or very close to it

[ny boy] 27/2/2017 13:55

This one could be a biggie, dips being bought, or short term traders getting mugged.

[trotterstrading] 27/2/2017 13:33

US military working with KMK on a ruggedised version of the D3S it could ultimately be as big an opportunity as the DARPA work.. I.e hundreds of $m's

[onedayrodders] 27/2/2017 13:29

Military spending on the up ...

[aishah] 27/2/2017 13:13

What is Putin up to? US 'nuclear sniffer' plane is sent to Britain as wave of deadly radioactive particles spreads across Europe

Read more:

KMK Quant Air can do the detection:

QuantAir® is a unique solution for in-field air monitoring that provides high performance and detection capabilities with accurate in-field quantification.

The lightweight system incorporates an optimised lead/copper shield enabling operation in both standard and raised backgrounds. This enables monitoring of potential activity build up and acts as a live warning system, allowing remedial actions to be carried out at the time of release. This minimises potential intake and increase worker safety.

Initially setup to measure 131I levels, QuantAir can be tailored to any radionuclide. It works with most current air sampling devices, including L60, L100 and Hi-Q air samplers measuring carbon cartridge Maypack filters with the potential of other configurations.

QuantAir® incorporates the Kromek GR1®, the world's smallest high-resolution room temperature gamma ray spectrometer utilizing a cadmium zinc telluride (CZT) detector and offering world-leading specification in a compact form. With an energy resolution of less than 2.5%, the GR1 provides clear separation of gamma energy peaks.

[ny boy] 27/2/2017 13:10

Yes broke resistance @ 25p, next resistance @ 29.20p

[daz] 27/2/2017 13:04

Yes, broken out of the downward channel

[mesquida] 27/2/2017 13:01

Chart break-out ?

[ny boy] 27/2/2017 12:48

Bought in last week, nice to see we are breaking higher on decent volumes.

[trotterstrading] 27/2/2017 12:31

Aha! Just wait till the herd arrive.. after meeting the CEO and CFO and discussing the company and prospects with them at length I have to say I have never been more confident in KMK

[onedayrodders] 27/2/2017 12:24

Cheers Mirabeau .. our paths keep crossing !

In this morning here at 25p and nice to be BEFORE the tip for change

;O)

[mirabeau] 27/2/2017 12:20

Simon Thompson of the IC

[onedayrodders] 27/2/2017 12:14

Simon who ?

[smartmoney100] 27/2/2017 12:07

Tipped by Simon T I'm told

[king kong dong] 24/2/2017 09:03

Level 2: 3 vs 1 - this is going up.

[pistonbroke1] 24/2/2017 09:01

Bit of a battle between buyer of 25K blocks and seller of 21795 blocks

[trotterstrading] 24/2/2017 08:41

Confidence returning an AMP selling is done, or very close to it. Time to load up IMHO.

[mesquida] 23/2/2017 18:26

A break above 25/26 would make the chart look very interesting, and if the seller is nearing the end of his line then such a break must be on the cards, perhaps even as soon as next week.

[quepassa] 23/2/2017 10:16

Well, they name DARPA NON-STOP and that's a USA government agency. they drop that name all the time.

still haven't named the Chinese $159m contract in the 4/4/14 RNS.

ALL IMO. DYOR.
QP

[king kong dong] 23/2/2017 10:00

Quepassa....a firm operating in security is unlikely to name names for obvious reasons

[aishah] 22/2/2017 13:04

Equity Development

£21m equity raise to accelerate growth
Published: Feb 22 2017
Kromek is pioneering digital colour imaging for x- and gamma rays, using cadmium zinc telluride crystals. Key markets include medical imaging, homeland security and nuclear detection.
When an army of ‘super smart’ fund managers snap-up a big holding in a rapidly expanding small-cap that owns ‘disruptive217; technology addressing multi-$billion markets, then it is usually worth taking note.This is exactly what has happened at Kromek, successfully completing its oversubscribed £20m placing and £1m open offer at 20p/share - supported by esteemed investors such as Gervais Williams at Miton (largest shareholder at 19.0%) and Katie Potts (Herald 5.35%), as well as others like Schroders (5.0%) and Killik (4.1%).
Kromek now combines exciting prospects with a ‘fortress-like’ balance sheet. In fact, the latter was the main reason behind the net £19.9m raise. Despite winning orders worth $35.5m over past 18 months (Book-to-Bill of 2.3x), a few customers were still nervous about awarding strategically important deals to the firm, because of its ‘perceivedR17; lack of financial ballast to produce commercial quantities of product, provide ongoing aftermarket support and backstop (if necessary) any associated T&Cs.
The capital injection might act as a catalyst for the company to land a number of significant orders over the next few months/quarters, indeed a 5 year deal in Security Screening has been announced today. The majority of future wins are expected to come from within its core verticals.

The Board encouragingly added on 25th January that trading was on track to meet FY17 consensus (adjusted PBT of -£3.7m on turnover of £8.8m-£8.9m), with the objective of achieving EBITDA breakeven in FY18 from sales of £12.5m. Given the forward visibility and £20m+ in the bank, we think this is achievable – underpinning our updated 34p/share DCF valuation, lower than before the placing simply due to the higher share count (153m vs 259m).